Racialized Drug Policy and Social Determinants in the U.S. Opioid Epidemic
Overview
This paper analyzes arguments from Hansen, Netherland, and Dasgupta regarding the opioid epidemic in the United States, challenging common perceptions of who is affected and examining the racialized history of drug policy. The analysis demonstrates that the epidemic's narrative has neglected communities of color while treating white addiction as a medical issue, and argues that effective interventions must address underlying social and economic determinants rather than prescribing practices alone.
What this essay covers
- Introduction: Overview of the opioid epidemic and its debated causes and consequences
- Analysis of Hansen and Netherland's arguments on racialized drug policy and the War on Drugs as targeting communities of color
- Dasgupta's examination of social and economic determinants including poverty, unemployment, and healthcare access
- Implications section discussing policy and public health approaches needed to address racial disparities and root causes
Preview
Student
Instructor
Course
Date
Opioid Epidemic
The opioid epidemic in the United States has concerned policymakers, healthcare professionals, and the public. While the crisis has been widely discussed in the media, the causes and consequences remain debatable. This paper examines arguments presented by Hansen and Netherland in their articles "Is the Prescription Opioid Epidemic a White Problem" and "The War on Drugs That Wasn't," as well as the article by Dasgupta titled "Opioid Crisis- No Easy Fix to Its Social and Economic Determinants." Through this analysis, I will explore how these articles challenge common perceptions of the opioid epidemic, its causes and the implications of these challenges for policy and public health approaches to the crisis.
In "Is the Prescription Opioid Epidemic a White Problem," Hansen and Netherlands challenge the notion that the opioid epidemic primarily affects white communities. The authors argue that the focus on the epidemic's impact on white populations has led to the neglect of other groups affected by the crisis, including communities of color. Hansen and Netherland suggest that the focus on white populations has its roots in the racialized history of drug policy in the United States, which has tended to criminalize drug use among people of color while treating drug addiction among white populations as a medical issue.